The Asia Factor Whitepaper

How Does a Smart Deal Maker “Play” This Region and Optimize the Capital Raising and Strategic Deal Making Opportunities? Authors: Hayato Watanabe, SVP, Head of Asia Koji Hirabata, Associate Stefanie Gan, Analyst Although their biopharma ecosystem dynamics...

Japan & China: So close yet so different

Having lived in Japan for more than 20 years, I have admittedly become perhaps a little too accustomed to the Japanese lifestyle. This is probably why after a few days in the hustle and bustle of Shanghai, I find myself looking forward to returning to the peace and...

Key trends impacting Japan partnering

Over the past years, I have had the fortune of participating in negotiations and ultimate deals between Western and Japanese biopharmaceutical companies. Doing deals is never easy, no matter the geography. However, it does seem that negotiating with Japanese companies...

Helping to Ensure Success After the Deal

One of my favorite places to hang out in Tokyo is the Apple Store in the Ginza area.  It is a beautiful four-story venue, complete with a theater (where one can sit and receive non-stop sessions on all of Apple’s products) and, of course, the Genius Bar.  One of the...

Japan Licensing Deals: A look back at 2016, and what to expect in 2017

On December 8th in Tokyo, Locust Walk hosted the 2nd annual “Locust Walk Japan Deal of the Year Award” event. We founded this event, which is co-sponsored by Clarivate Analytics (formerly Thomson Reuters), to celebrate the deals consummated throughout the year by...